Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: mr. is a 48-year-old male with worsening symptoms related to severe 3-vessel disease. major surgical or invasive procedure: cabg x4 (lima-lad, svg to , , acute marginal) history of present illness: mr. is a 48-year-old male with worsening symptoms related to severe 3-vessel disease. he is on hemodialysis with end stage renal disease from diabetes and its complications. he is presenting for revascularization. past medical history: # insulin-dependent diabetes for 20 years: hga1c 9.4% on # hypertension # hyperlipidemia with markedly elevated tgs # ckd (mid 2s to most recently) # pancreatitis; pancreas divisum # obesity # hyperuricemia # gerd social history: patient is married with five children. patient with disability due to poor vision from diabetic retinopathy. wife works at . denies tobacco. rare etoh. family history: mother and father with diabetes, no coronary disease, no colon cancer, no prostate cancer. pertinent results: wbc rbc hgb hct mcv mch mchc rdw plt ct 07:00am 6.9 3.04* 9.2* 28.5* 94 30.4 32.5 16.2* 176 basic coagulation (pt, ptt, plt, inr) pt ptt plt ct inr(pt) 07:00am 176 basic coagulation (fibrinogen, dd, tt, reptilase, bt) fibrino 12:03pm 138* chemistry renal & glucose glucose urean creat na k cl hco3 angap 07:00am 116* 49* 6.1*# 134 4.7 95* 26 18 estimated gfr (mdrd calculation) estgfr 02:54am using this1 source: line-midline chemistry totprot albumin globuln calcium phos mg uricacd iron 07:00am 6.5* 3.0 2.2 brief hospital course: mr. is a 48 yr old man with cad on hd while awaiting transplant. he was taken to the or on for a cabg x4 (lima-lad, svg to om, and acute marginal) . see operative note for details. mr. remained intubated and on neosynephrine and was transferred to the icu for ongoing invasive monitoring. he was weaned from the vent and successfully extubated on pod#1. he received ongoing hemodialysis throughout his hospital stay. he was transferred from the icu on pod #1. returned to the icu on pod#2 for hyperglycemia. was consulted to manage hyperglycemia. mr. was transferred from the icu to the floor again on pod#4 with improved glycemic control. his chest tubes were removed and cxr was without evidence of pneumothorax. he was given a dose of betablocker and became bradycardic but remained hemodynamically stable. once hr stabilized, his pacing wires were d/c'd. on pod#5 he was noted to have serosanguinous drainage from the lower of his sternal wound. his wbc was normal and remained afebrile. he was started on keflex. his chest xray revealed a moderate left effusion from which he was asymptomatic with room air oxygen saturations of 97%. he was evaluated by physical therapy and cleared for discharge to home on pod#7. medications on admission: carvedilol 6.25(2),cinacalcet 30(2),doxazosin 4(2),tricor 145(1), fluoxetine 10(1),irbesartan 300(1), omeprazole 20(1), novolog 70/30(45 in am and 20 in pm), pravachol 40(1), sevelamer hcl 800(1), torsemide 2091), calcium acetate 667(3)w/meals, nephrocaps 1(1) discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). 4. fluoxetine 20 mg capsule sig: one (1) capsule po daily (daily). 5. pravastatin 20 mg tablet sig: two (2) tablet po daily (daily). 6. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 7. fenofibrate micronized 145 mg tablet sig: one (1) tablet po daily (daily). 8. hydromorphone 2 mg tablet sig: 1-2 tablets po q3h (every 3 hours) as needed. disp:*65 tablet(s)* refills:*0* 9. glargine sig: seventeen (17) units subcutaneously at breakfast. disp:*1 vial* refills:*2* 10. humalog 100 unit/ml solution sig: as directed units subcutaneous before meals and at bedtime: dose according to sliding scale. disp:*1 vial* refills:*2* 11. captopril 25 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*2* 12. calcitriol 0.25 mcg capsule sig: one (1) capsule po daily (daily). 13. cephalexin 500 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 5 days. disp:*20 capsule(s)* refills:*0* discharge disposition: home with service facility: vna discharge diagnosis: coronary artery bypass graft x4(lima->lad/svg->/om3/acute marginal)- -htn -hyperlipidemia -diabetes -neuropathy -retinopathy -nephropathy,esrd-hemodialysis on monday/wednesday/friday - on transplant list - biventricular cardiomyopathy - gastritis - osa -pancreatitis '-h/o pancreatic division -depression -obesity left brachiocephalic av fistula s/p angioplasty ' s/p thrombectomy ' s/p lue graft placed' discharge condition: good discharge instructions: please shower daily including washing incisions, no baths or swimming monitor wounds for infection - redness, drainage, or increased pain report any fever greater than 101 report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week no creams, lotions, powders, or ointments to incisions no driving for approximately one month, and while taking narcotics no lifting more than 10 pounds for 10 weeks please call with any questions or concerns followup instructions: dr. in 4 weeks () please call for appointment dr , h. in 1 week please call for appointment dr , in weeks please call for appointment **wound check appointment 6 as instructed by nurse (in 4 days, fri. : inferior pole serous sternal drainage/keflex course procedure: (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery diagnostic ultrasound of heart hemodialysis cardioplegia transfusion of packed cells diagnoses: other primary cardiomyopathies anemia in chronic kidney disease end stage renal disease obstructive sleep apnea (adult)(pediatric) renal dialysis status coronary atherosclerosis of native coronary artery esophageal reflux intermediate coronary syndrome congestive heart failure, unspecified polyneuropathy in diabetes paroxysmal ventricular tachycardia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia obesity, unspecified acute on chronic systolic heart failure diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled 

Answer: The patient is high likely exposed to